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ABSTRACT  
The oral route of drug delivery is commonly utilized for administration of medicines and is particularly preferred for the tr eatment of many 
chronic diseases which require continuous ingestion over a reasonably prolonged period of time. However the oral delivery of lipophilic drugs 
presents a major obstacle because of their low aqueous solubility. The aqueous solubility of a drug is a crucial determinant of its dissolution 
rate, absorption and bioavailability. Drugs with relatively high intrinsic lipophilicity can be dissolved in appropriate mixtures of oils/lipids, 
surfactants, cosolvents which can rapidly form oil-in-water (o/w) fine emulsions when dispersed in aqueous phase under mild agitation or 
mixing. These isotropic self-emulsifying formulations or self-emulsifying drug delivery systems are effective for delivery of poorly soluble, 
lipophilic drugs by dispersing the drugs within fine oil droplets in emulsions and this solubilization of drugs can then improve its absorption, 
bioavailability and therapeutic efficacy. The present paper reviews the concept, design, formulation, characterization and applications of self-
emulsifying formulations. 
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Self-emulsifying formulations are blends of oil, surfactant, 
co-solvent and solubilized drug that appear as isotropic 
dispersions 1. These unique formulations can rapidly 
transform to oil-in-water (o/w) emulsions with fine droplets 
when dispersed in aqueous medium under mild agitation. 
The described preparations are known as self-emulsifying 
drug delivery systems (SEDDS). Oil-soluble active 
compounds can be dissolved or dispersed in the oily phase 
and distributed across the biological systems within fine oil 
droplets carried in aqueous medium. SEDDS are commonly 
referred to as self-microemulsifying drug delivery systems if 
they form microemulsion with nano range droplet size. The 
rapid emulsification of these formulations in the 
gastrointestinal tract can facilitate improved oral 
bioavailability and a reproducible plasma concentration. The 
self-emulsifying capacity of the formulation augments the 
natural emulsifying activities of the GIT bio-structure. The 
droplet size of the emulsion would affect the extent and rate 
of absorption of the orally administered drug with smaller 
sizes usually improving absorption, bioavailability and 
efficacy of bioactive compounds. A drug substance would 
require high lipophilic properties for it to qualify as 
candidate to be delivered as SEDDS since the active 
ingredient should be dissolved in a relatively small amount 
of oil. This condition is necessary so that the volume of oil 
required to solubilize the required total dose of the 
medicament would not be unnecessarily high. High chemical 
stability of the dissolved drug in oil phase is highly desired 
for the lipid formulations. The functional groups in the drug 
which may be vital for bioactivity should not chemically 
interact with groups in the oil phase which may cause 
reduced activity, loss of activity or emergence of unwanted 
toxicity. 
Self-emulsifying drug delivery systems are homogenous 
mixtures of natural or synthetic oils, surfactants and 
cosolvents/cosurfactants 2. These systems are able to self-
emulsify rapidly in gastro-intestinal fluids to form fine 
oil/water emulsions under the gentle agitation or mixing 
that occurs in the gastro-intestinal tract due to peristaltic 
movements. 
Lipids 
Lipids are a group of naturally occurring substances that 
include fats, waxes, monoglycerides, diglycerides, 
triglycerides, phospholipids and other lipidic molecules. The 
main biological functions of lipids include storing energy, 
providing structural components of cell membranes and 
signaling 3,4. Lipids are being effectively applied in 
pharmacy, cosmetics, food, nanotechnology, et c. 
Solubilization of the drug in the oily phase and access to the 
lymphatic circulation depend on the type and amount of oil 
applied for formulation since different oils have different 
fatty acid constituents which are also present in different 
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combinations. Digestive lipids such as tri- and diglycerides, 
fatty acids, cholesterol, phospholipids, and other lipids that 
are synthesized lead to improvement in bioavailability of the 
drug whereas non-digestible lipids cause reduced 
bioavailability due to inhibitions in absorption because there 
may be retention of some quantities of administered drug in 
the preparations. Although edible oils based on natural 
origin are promising, they may not be useful because they 
usually do not have sufficient capacity to solubilize large 
amount of drugs with high lipophilic properties and self-
emulsification can be problematic in these cases because of 
the presence of large molecular volume 5. The polarity of the 
droplets is governed by the Hydrophile-Lipophile Balance 
(HLB), the chain length and degree of unsaturation of the 
constituent fatty acid, the molecular weight of the 
hydrophilic section and the concentration of the emulsifier. 
Actually, the polarity portrays the affinity of the drug for oil 
and/or water, and the type of forces formed between the 
interacting components. A high polarity of the dispersed 
droplets will promote a rapid rate of release of the drug into 
the continuous aqueous phase. Lipids can be grouped into 
homolipids, heterolipids and complex lipids. 
Homolipids 
Homolipids are esters of fatty acids with different alcohols. 
The focal lipids are long chain and medium chain fatty acids 
linked to a glycerol molecule, and these lipids are known as 
triacylglycerols. The long-chain fatty acids ranging from C14 
to 24 are widely found in common fat while the medium 
chain fatty acids ranging between C6 and 12 are typical 
constituents of coconut oil or palm kernel oil. 
Triacylglycerols or triglycerides have different physical and 
chemical properties which depend on the length of the 
carbon chain, the number and position of double bonds, and 
spatial arrangement. Most natural fatty acids occur as cis-
configuration, although trans-fatty acids are known to exist 
also in seed oils from different plant families 
(Ranunculaceae, Lamiaceae or Asteraceae), milk, meat and 
some partially modified dietary fats (margarine) 6. 
Structured lipids are triacylglycerols that contain mixtures 
of any of short-chain or medium-chain fatty acids or both 
and long-chain fatty acids, mostly esterified on the same 
glycerol molecule 7. Homolipids include glycerides (fats, 
oils), cerides (waxes), and sterides. Diacylglycerols are found 
in vegetable oils in low amounts. They are formed as 
intermediate products in biosynthesis of triacylglycerols, as 
well as by acidic and enzymatic hydrolysis during oil 
extraction, refining process and storage. 
Chemically, fats are triglycerides, triesters of glycerol and 
any of several fatty acids. Fats can present as solid or liquid 
at room temperature depending on their structure and 
composition. ‘Oil’ is usually used to refer to fats that are 
liquids at room temperature while ‘fats’ is usually used to 
refer to fats that are solid at normal room temperature. Fats 
and oils are forms of lipids. Fats can be saturated or 
unsaturated. Examples of fats include lard, tallow, butter, 
goat fat et c. Natural waxes are usually esters of fatty acids 
and long chain alcohols. Chemically, a wax is a type of lipid 
that may contain a wide variety of long chain alkanes, esters, 
polyesters and hydroxy esters of long-chain primary 
alcohols and fatty acids. Waxes are not glycerides, they lack 
triglycerides which are esters of glycerol and three fatty 
acids and this distinguishes them from fats. Fats (and Oils) 
are triglycerides or triacylglycerols and consist of glycerol 
combined with three fatty acid molecules. In addition, waxes 
are esters of an alcohol (except glycerol) and a single long 
chain acid. Cetyl palmitate is a typical wax. There are animal 
and plant waxes. Examples of animal wax are beeswax, 
earwax, shellac wax, spermaceti, et c, while plant wax 
includes carnauba wax, candelila wax, et c. However, ‘fat’ is 
seen as a general term which encompasses all these groups. 
Modified and hydrolyzed oil of vegetable origin usually have 
good emulsification properties and are biocompatible. 
Triglycerides with long and medium chain lengths at 
different degrees of saturation are used in the formulation of 
self-microemulsifying drug delivery systems.  
Heterolipids 
Heterolipids include phospholipids. Phospholipids can be 
obtained from different biological sources. However, sources 
of heterolipids are largely limited to vegetable oil seeds such 
as soyabeans, for pharmaceutical and some nutriceutical use 
while the egg yolk and milk have gained importance as 
reliable sources of phospholipids 8. Phospholipids are 
usually of the phosphoglyceride type, although 
phosphingolipids are also available. Phosphoglycerides are 
also commonly called lecithin. They are typically 
phosphatidylcholines.  
Complex lipids 
Complex lipids are usually used to describe lipoproteins. 
Lipoproteins are spherical lipid-protein complexes that are 
responsible for the transport of cholesterol and other lipids 
within the biological system. Based on structural 
examination, lipoprotein comprises an apolar core 
containing cholesterol esters or triacylglycerols, covered by 
a distinct monolayer of phospholipid in which cholesterol 
and one or more specific apoproteins are embedded. 
Basically, lipoproteins transport lipid molecules in water. 
These heterogenous complex aggregates of lipid and protein 
are abundant in biological systems and natural lipoproteins 
include chylomicron, very low density lipoprotein (VLDL), 
low density lipoprotein (LDL) and high density lipoprotein 
(HDL). The different existing lipoproteins vary in size, 
density, lipid and apoprotein composition 9. 
Self-microemulsifying drug delivery systems are 
homogenous mixtures of natural or synthetic oils, 
surfactants, or alternatively, one or more hydrophilic 
solvents and co-solvents/ co-surfactants, which upon mild 
agitation following dilution in aqueous media form fine oil-
in-water (o/w) microemulsions. The droplet sizes are 
usually very small allowing for transparency. 
Mechanism of self-emulsification and parameters 
In emulsification process, the associated free energy (ΔG) is 
given by the equation 1:  
ΔG = ∑Niπri2 σ --------------------------------------------1 
“N” is number of droplets with radius “r” and “σ” denotes 
interfacial energy. 
Self-emulsification occurs when the change in entropy that 
promotes dispersion is higher than the energy needed to 
elevate the surface area of the test dispersion 10. The ease 
with which the degree of disorder or randomness of a 
system can change would determine the ease of self-
emulsification. The energy gradient is a key element of the 
process. The free energy of the conventional emulsion is 
directly related to the energy required to create a fresh 
surface between the oil and water phases and is described 
by the equation above. The two phases of emulsion 
ultimately separate with time to reduce the interfacial area 
and the emulsion is stabilized by emulsifying agents, which 
form emulsion droplets, reduce the interfacial energy and 
provide a barrier to prevent coalescence 11.  A method has 
been developed for quantitatively assessing the ease of 
emulsification by monitoring the turbidity of the oil-
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surfactant system in a water stream. The conclusion was 
that the emulsification process may be associated with the 
ease with which water penetrates the oil-water interface, 
with formation of liquid crystalline phase resulting in 
swelling at the interface, thereby causing a greater ease of 
emulsification 12. The thermotropic stability of self-
microemulsifying formulations (SMEFs) and their high drug 
loading capacities make them potential delivery systems for 
low aqueous soluble drugs 13. 
The process of self-emulsification proceeds through 
formation of liquid crystals (LC) and gel phases. The 
physico-chemical and mechanistic process of drug release 
from SEDDS is highly dependent on LC (liquid crystals) 
formed at the interface, since it is most likely to affect the 
angle of curvature of the droplet formed and the inhibitions 
to drug accumulation in aqueous media 14.   
Microemulsion properties such as phase behaviour, 
structure of the system, temperature-dependent stability, 
and solubilisation capacity, depend on some characteristics 
of the formed interfacial films. The interfacial tension, 
spontaneous curvature and film rigidity are properties of the 
interfacial films that can be used to design effective and 
stable microemulsions. Other variables that are external 
(such as temperature) and additives (such as salt) affect 
multiple properties simultaneously which suggest 
associative capabilities. Increase in the salt concentration in 
an emulsion system containing a surfactant, changes the 
interfacial tension, adjusts the spontaneous curvature 
towards a favoured direction and modifies the surface-active 
agent’s adsorption affinity and phase attraction. 
The oil-water interfacial tension (γow) is the work needed to 
increase the area of an interface by unit amount. Lowering 
γow to a value that favours stable emulsion formation can be 
achieved using surfactant-co-surfactant mixture. The 
inclusion of co-surfactant creates a synergistic effect that 
augments the benefits of surfactants. Solubilization 
capacities of the surfactant system are improved when such 
binary systems are applied. It has been discovered that 
temperature, pressure, chain length of oil or fatty acid 
components, and additives such as salt and alcohol, affect 
the water-oil interfacial tension in the presence of ionic or 
non-ionic surfactants. These factors affect the stability of 
emulsions and SEDDS. 
When a comparable amount of water and oil is mixed in the 
presence of surfactant, the film curvature is known as the 
spontaneous curvature H° (also known as the natural or the 
preferred curvature). With the weights or volumes of the oil 
and water approximately equal, it is believed that a 
spontaneous action occurs with little or no favour for the 
emergence of one rather than the other. In this situation, 
there is no constraint on the emulsion to align into curvature 
of any particular value, or type, so the surfactant film is free 
to adopt the lowest free energy state. This freedom of 
orientation changes with changes in relative composition or 
interferences. The curvature is not spontaneous if the 
amount of one component (either oil or water) is very small 
when compared with the other component. This huge 
difference between the two components forces or favours 
the curvature to take a set of values or orientations. The 
absolute mean value of any curvature can be calculated 
using some geometric models.  
For easier understanding one can denote positive curvature 
as concave towards oil which then favours o/w emulsion 
and apply negative for a curvature concave towards water 
for water-in-oil emulsion.  
The spontaneous curvature depends on the type and 
structure of the microemulsion components and on the 
prevailing conditions of the system. In a case of water-oil-
surfactant system where H° = 0 (i.e. planar interface) where 
the surfactant is ionic, it has been observed that salinity and 
temperature affect H° in different, usually opposite, ways. 
Increment in the saline content shields the electrostatic 
repulsion between head groups, and this would cause 
reduction in the effective area per surfactant head group. 
This ‘charge shielding’ allows the head groups to 
consolidate. Consequently, H° decreases, appear negative 
and hence curved toward water for a water-in-oil emulsion. 
Temperature increment has a significant effect of increasing 
dissociation of counter-ion, which promotes electrostatic 
repulsion between head groups, and consequently increases 
H°. Spontaneous curvature expresses the sign and magnitude 
of the preferred curvature of a single surfactant monolayer 
with smaller microemulsion droplets being more curved 
than larger ones. The expressions of salt and temperature 
effects are different for non-ionic surfactants. This is because 
their mode of interference on the functionality of surfactant 
and interfacial environment differs. Salt has very little or no 
significant effect on H° for non-ionic surfactant systems, 
whereas temperature has huge effect on non-ionic agents 
when compared with ionic surfactants. The reason for this 
pronounced temperature effect is that the solubility of non-
ionic surfactants in water or oil depends crucially on 
temperature. In the case of certain non-ionic ethoxylated 
surfactants and when spontaneous curvature does not 
favour any particular direction, increasing the temperature 
causes the surfactant to be more soluble in oil which favours 
orientation to form a negative (w/o) curvature. Increase in 
temperature causes a transition from o/w to bicontinuous 
structures to w/o microemulsions. Also, amount of oil that is 
solubilized in the emulsion starts increasing as the 
temperature increases. For this category of surfactants, 
increments in temperature by some degrees are enough to 
modify the curvature from highly positive to highly negative 
leading to water-in-oil emulsion. Apart from temperature 
and salinity or electrolyte concentration, other factors that 
can affect H° include surfactant chemical structure, use of 
mixed surfactants, surfactant chemical bonds, type and 
valency of counter ions, chemical structure and chain length 
of the lipid, and solubilisation of applied adjuncts in the 
system. Ho depends on the chemical structure of the surface-
active molecules and it increases with increase in HLB value 
to favour oil-in-water microemulsion and self-emulsification. 
The Ho decreases as the tail length is increased for a given 
head group and this corresponds to rise in lipophilicity. 
Surfactant film rigidity also greatly determines 
microemulsion properties. Helfrich (1973), established a 
film bending energy model and presented two elastic moduli 
to describe film     rigidity 15. These are the mean bending 
elastic modulus (describing rigidity) which represents the 
energy required to bend a unit surface area by unit value 
and secondly the Gaussian (or saddle-splay) modulus, which 
is a term used to describe film topology.  
A number of attempts for predicting the likely 
microemulsion type that result from a mixture of oil, water 
and emulsifier(s) have been made. Emulsion types can be 
predicted using a rule (now known as Bancroft’s rule), which 
states that water-soluble emulsifiers tend to form oil-in-
water emulsions and oil-soluble emulsifiers tend to form 
water-in-oil emulsions 16. However, this is very qualitative, 
and therefore, it is necessary to look at the quantitative 
angle. Free surfactants are always present in the continuous 
phase which allows for stable droplet formation in 
microemulsions. This also allows self-emulsification in 
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SEDDS. There is an entropy change for the self-assembling of 
free surfactant to the interface of a single oil or water 
droplet for o/w or w/o emulsions, respectively. 
The packing of molecules at the interface of oil and water, or 
in an aggregate, depends on the geometric characteristics of 
the surfactant, and these include effective area per 
surfactant head group ah, the volume of the hydrophobic tail 
υ, and chain length lc 17. These properties are vital in 
predicting the behavior of surfactants under different 
conditions. This is because the dynamics of surfactant self-
assembly is modulated by these characteristics. The 
hydrophobic volume υ and tail length lc are determined by 
the steric inhibitions of repulsive interaction between 
surfactant tails and also determined by oil penetration. 
These interactive properties can be used to predict 
aggregate structures by utilizing the ‘packing parameter’ 
(υ/ahlc). The usefulness of the packing parameter lies in its 
application to estimate the shape of surfactant aggregates. 
Surfactants with charged head groups tend to possess large 
head group area which supports formation of spherical 
micelles while those with smaller head group area arranges 
into cylindrical (rod-like) shapes. 
One of the benefits of using combinations of surfactants is 
the opportunity to formulate microemulsions that are 
temperature-insensitive. Mixing ionic and non-ionic 
surfactants types can yield temperature-insensitive 
microemulsions or different products with varied levels of 
sensitivity because the dependence of the monolayer 
curvature on temperature is opposite for ionic and non-ionic 
surfactants. 
The Gibbs adsorption isotherm for multicomponent system 
relates the changes in quantities of a component in direct 
contact with a surface with changes observed in the surface 
tension of the system. These changes in interfacial tension 
causes a corresponding change in surface energy and this 
can be applied in emulsion systems 18. For a two-component 
system, the Gibbs adsorption equation can be expressed to 
show surface excesses using Equation 2:  
-d γow = Γ1 dμ1 + Γ2 dμ2 -----------------------2 
Where γow represent the surface tension, Γ1 and Γ2 
signifies surface excesses of components 1 and 2, and μ1 and 
μ2 are the chemical potentials of components 1 and 2. 
Equation 2 relates interfacial tension to interfacial 
composition (or surface /interfacial excess) and chemical 
potential of mixture components. This relationship can be 
used to show the value of using both surfactant and co-
surfactant or cosolvent in the formulation of self-emulsifying 
formulations. 
Advantages and limitations of SEDDS 
Some active pharmaceutical ingredients have been 
formulated as SEDDS and studied extensively. Some of the 
potential advantages of SEDDS 19 include: 
1. Improved oral bioavailability which allows for dose 
reduction 
2. Consistency and reproducibility of drug absorption 
profiles 
3. Selective drug targeting toward a definite absorption 
channel in the G1 tract 
4. Drug protection or ‘shielding’ from the hostile 
environment in the gut or environment  
5. Controlled drug delivery 
6. Presentation as liquid or solid dosage forms. 
7. Reduced variability  
8. High drug payloads especially when using lipids with 
high drug solubility 
Mechanism of enhanced bioavailability 
Mechanisms suggested for the reported enhanced drug 
absorption and bioavailability of many drugs from these self-
emulsifying systems include; 
-  Increase in membrane fluidity that facilitates transcellular 
absorption,  
-  Opening tight junction in the biological system to allow 
paracellular transport,  
-  Inhibition of P-glycoprotein for increase in intracellular 
accumulation of drugs and residence time in the GIT      
- Large interfacial surface area due to fine dispersed droplet 
size of the formulation promotes rapid release of drug 
substances 20. 
-  Stimulating bio-production of lipoprotein and chylomicron 
by lipids and these products improve drug absorption and 
biodistribution 
Certain lipids and surfactants may magnify the activity of 
intestinal efflux transporters as indicated by the P-
glycoprotein efflux pump and may also decrease the level of 
enterocyte-based metabolism 21. The formation of 
lipoproteins promotes lymphatic transport of highly 
lipophilic drugs and increases the bioavailability through 
reduction in first pass metabolism 22. Lipids (eg 
triglycerides) affect the oral bioavailability of drugs by 
improving the dissolution rate and solubility in the intestinal 
fluid, protecting the active compound from chemical and 
enzymatic degradation and through the formation of 
lipoproteins promoting lymphatic transport of highly 
lipophilic drugs 23. Administration of lipophilic drugs using 
lipids as carriers may enhance drug absorption into the 
portal blood compared with those lacking lipids 24. Many 
drugs degrade in the physiological system through 
enzymatic or hydrolytic cleavages under acidic pH of 
stomach. Such drugs when presented in form of SEDDS can 
be protected against these degradative processes. The use of 
SEDDS as vehicles for bioactive drugs provides a barrier 
against degradation factors. 
A major limitation of SEDDS is the requirement for high 
concentration of surfactants which might cause some side 
effects such as irritation. Also the drug might be trapped in 
the micelles of the surfactant and this may negatively affect 
its availability for activity. 
Excipient selection in SEDDS 
Optimized pharmaceutical excipient combinations generate 
efficient self-emulsifying systems 25. The mixture of oil, 
water and surfactants is able to form a wide range of 
structures and phases depending upon the proportions of 
each of these components. Generally regarded as safe 
(GRAS) excipients are usually employed in the preparations 
of SEDDS. Therefore a careful selection of components is 
usually required before SEDDS formulation. 
Oil/ Lipid phase 
This is an important component of any SEDDS. The main 
criterion for selecting the oil phase is that the drug should 
have a high solubility in it. Identifying the suitable oil having 
the maximum solubilizing capacity for the drug under study 
is very important to achieve optimum drug loading 26. This 
will minimize the volume of the formulation necessary to 
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deliver the therapeutic dose of the drug especially if it needs 
to be filled into capsules. Some natural oils can be processed 
to remove impurities and/or various fractions isolated and 
used to prepare lipid-based products. Naturally occurring 
oils and fats are made up of triglycerides consisting of fatty 
acids of varying chain lengths and degrees of unsaturation. 
The melting points of these lipids and their susceptibility to 
oxidation increases as the degree of unsaturation increases. 
Triglycerides are classified as short (< 5 carbons), medium 
(6-12 carbons) or long chain (> 12 carbons). Long chain and 
medium chain triglyceride oils with different degrees of 
saturation are commonly used. These triglycerides may be 
synthetically hydrogenated to decrease the degree of 
unsaturation, thereby conferring resistance to oxidative 
degradation. Structured lipids are triacylglycerols that 
contain mixtures of either short chain or medium chain fatty 
acids or both, and long chain fatty acids, preferably esterified 
on the same glycerol molecule 7. Highly lipophilic drug (log𝑃 
> 5) with high solubility in triglycerides (>50mg/mL) can 
undergo lymphatic transport when co-administered with 
esters of unsaturated long chain fatty acids, thereby 
improving the bioavailability of the drug 27 
Digestive lipids including triglycerides, diglycerides, fatty 
acids, phospholipids, cholesterol and other synthetic 
derivatives are suitable oils for development of delivery 
systems for lipophilic compounds 28. Oils with medium 
hydrocarbon chain length and oils with short chains are 
easier to emulsify than their long chain triglyceride 
counterparts 29. Many combinations of lipids and their 
digestion products and surfactants have been shown to have 
permeability or absorption enhancing qualities 30. It is vital 
to always consider the physical aging and oxidation of the 
oils. The choice of lipids to be used then usually depends on 
consideration of a whole lot of factors which are related to 
functionality, safety and stability. 
Surfactants  
The most commonly accepted surfactants for SEDDS are 
non-ionic surfactants possessing relatively high hydrophile-
lipophile-balance (HLB) values. The non-ionic surfactants 
are highly hydrophilic based on the hydrophilicity of the 
head. The hydrophilicity of the surfactants facilitates the 
spontaneous formation of oil-in-water emulsion globules 
and rapid dispersion of the preparation in aqueous media. 
The flexibility of the surfactant film is necessary and enables 
the existence of several structures including droplet-like 
shapes, aggregates, bicontinuous structures and multiple 
phase behaviours 31. The surfactant concentration ranges 
between 30 %w/w and 60 %w/w in order to form stable 
SEDDS 1. At higher surfactant concentrations (approximately 
> 50 – 60 %w/w), the progress of emulsification may be 
affected by the formation of viscous liquid crystalline gels at 
the oil/water interface. The interfaces of microemulsions are 
stabilized by carefully selected combinations of surfactant 
and/or co-surfactant based on appropriate design space to 
achieve quality by design (QbD). These combined agents are 
expected to complement each other. The addition of 
cosolvents such as short chain alcohols imparts flexibility to 
the interface that assists the free movement of the 
hydrophobic tails of surfactant at interface and this would 
consequently affect dynamic behavior of microemulsions 32. 
The ingredient mixtures with higher surfactant and co-
surfactant / oil ratios resulted in the formation of self-
microemulsifying formulation 33. Some naturally occurring 
polar lipids have emulsifying capacity. 
There is an increasing interest in the use of non-ionic 
tensides both as a surfactant and as a co-surfactant due to 
high stability, high performance, low toxicity, low irritancy 
and desirable biodegradability of many non-ionic 
surfactants 34. However, compositional variables such as 
lipid content, presence of other amphiphilic entities, 
hydrophilic molecules or electrolytes and temperature may 
affect arrangement of the surfactant molecule and its 
efficiency to form microemulsion 35. It has been generally 
observed that single chain surfactants alone do not 
sufficiently reduce the oil/ water interfacial tension to allow 
formation of a microemulsion 36. The critical micellar 
concentration (CMC) of high performing surfactants is 
smaller than those of weaker surfactants, and these more 
effective ones require less mass fraction to form a 
homogenous and stable microemulsion. The efficiency of a 
surfactant can be viewed from the amount of an amphiphile 
required to completely homogenize same quantities of oil 
and water 5.  
There is a relationship between the droplet size and amount 
of surfactant being employed, which implies that changes in 
surfactant concentration can directly affect droplet size. 
Increasing the surfactant concentration may result in the 
creation of droplets with smaller mean droplet size. This 
outcome could be described by the stabilization of the oil 
droplets because of localization of the surfactant molecules 
at the oil-water interface 37. However, reports have shown 
that in some few cases the mean droplet size increase with 
greater surfactant concentrations 38. This behavior could be 
attributed to the interfacial disruption caused by increased 
water penetration into the oil droplets facilitated by 
increased surfactant concentration, causing movement of oil 
droplets into the aqueous compartment. 
Digestion of surfactant can change the solubilization 
environment of the drug which consequently cause 
precipitation of the poorly water soluble drugs inside the 
GIT 39. The efficiency of self-emulsification is usually related 
to the Hydrophile-Lipophile Balance (HLB) value of the 
surfactant 40. Surfactants are crucial components for the 
formulation of self-emulsifying formulations; however large 
amounts of surfactants cause skin irritation and wound 34. 
Co-solvents/ co-surfactants 
Co-solvents like diethylene glycol monoethyl ether 
(Transcutol®), propylene glycol, glycerin, polyethylene 
glycol (PEG) and many others, may help to solubilize large 
amounts of hydrophilic surfactants or the hydrophobic 
drugs in the lipid base. The physical state of these excipients 
at ambient temperature is determined by their molecular 
weight. PEG with molecular weight ranging from 200 to 600 
is liquid at room temperature whereas those possessing 
molecular weight of 1000 and above, exist as thermo-
softening semisolids. These solvents sometimes play the role 
of the co-surfactant in the microemulsions or SEDDS. The 
use of alcohol has some disadvantages when self-emulsifying 
formulation is incorporated in capsule shells causing 
leaching of capsule shells due to the presence of alcohol 41. 
Polyethylene glycols are also known to contain varying 
amounts of peroxide impurities and derivatives formed by 
autoxidation which can activate chemical instability of the 
incorporated drug substances 42. These impurities may 
chemically react with the active ingredient. These changes 
can be detected using technologies such as Fourier 
Transform Infra-Red Spectroscopy (FTIR), High 
Performance Liquid Chromatography (HPLC), Differential 
Scanning Calorimetry (DSC) and Gas Chromatography-Mass 
Spectroscopy (GCMS) etc 
In selecting a suitable vehicle for self-emulsifying liquid 
preparations, drug solubility in various constituents, 
identification of emulsifying regions from pseudoternary 
phase diagram and resultant droplet size distribution need 
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careful assessment and monitoring 43. The digestibility and 
safety of the excipients should always be considered. 
Digestion of formulations will inevitably have high effect on 
the state of dispersion of the lipid formulation and the 
biofate of the drug 44. Digestion of dietary triglycerides in the 
small intestine is very rapid and other non-ionic esters such 
as mixed glycerides and surfactants are also substrates of 
pancreatic lipase 45. 
The solubility of the drug in the oils and surfactants can be 
determined using the shake flask method while 
pseudoternary phase diagrams can be developed to identify 
microemulsifying regions using the water titration method. 
SEDDS are usually used to enhance the oral bioavailability of 
poorly soluble drugs (especially highly lipophilic drugs). The 
loaded drugs usually belong to the biopharmaceutics 
classification system (BCS) class II with low solubility and 
high permeability. SEDDS can be expressed as self-
microemulsifying drug delivery system (SMEDDS) or self-
nanoemulsifying drug delivery system (SNEDDS) depending 
on the size range of the oil droplet.  
Therapeutic agents can have a tangible effect on the 
characteristics of SEDDS, such as phase characteristics and 
emulsion droplet size. Physical and chemical properties of 
the active compounds, such as log P, molecular structure and 
weight, presence of ionizable groups, pKa, all have 
significant impact on the effectiveness of SEDDS. It was 
observed that the addition of cefpodoxime proxetil, in self-
nanoemulsifying formulations (SNEFs) reduced the nano-
emulsification region in the design space when water was 
used 46. It was observed that as pH of aqueous phase was 
changed to 1.2, the nano-emulsification region expanded 
because of pH-dependent solubility of the drug. Moreover, 
inclusion of bioactives into the formulations could increase 
the nanoemulsion droplet size relative to formulations 
without drug. Similar results have been reported using 
flurbiprofen 47. The globule size of the emulsion rose with 
increasing concentration of drug in the SNEFs. Some drugs 
show surface activity and these include sodium salicylate, 
ascorbic acid and tricyclic amines, that may show different 
characteristics with an increasing concentration in 
formulation. Another investigation showed an enlargement 
of the self nanoemulsification region upon increasing the 
concentration of simvastatin 4-fold in the SNEFs. These 
reports showed that simvastatin could have moderate co-
surfactant effect at the oil and water interface because of its 
amphiphilic nature 48. Computational analysis proposed that 
a high number of rotatable bonds in the drug may interact 
with the surfactant and co-surfactant molecules. Flexibility 
of a molecule facilitates the formation of closely-packed 
stable interfacial film that forges very stable nanoemulsions.  
Characterization of SEDDS   
 (i)  Visual assessment 
The self-emulsifying property of the blends and appearance 
of the dispersion can be understood by visual examination 
49. 
(ii)  Self-emulsification time 
The self-emulsification time is the time for a pre-concentrate 
SEDDS to form a homogenous, stable mixture upon dilution/ 
titration under specified conditions.  
(iii)  Turbidity measurement 
This parameter reveals efficient self-emulsification by 
establishing if the preparation reaches equilibrium rapidly 
and efficiently 50, with observation of changing turbidity as 
the process of self-emulsification progresses. Turbidimetric 
evaluation can be performed to measure the increase in 
turbidity until equilibrium, using a turbidimeter. 
(iv)  Droplet size 
The droplet size distribution of SEDDS diluted with water 
can be determined by photon correlation spectroscopy 
based on the laser light scattering phenomenon. Microscopic 
techniques can also be used. The reduction of the droplet 
size to values below 50 µm leads to the formation of self-
microemulsifying drug delivery systems (SMEDDS), which 
are stable, isotropic and clear o/w dispersions. 
Polydispersity is basically calculated from the standard 
deviation and the mean droplet size 51, although 
computational techniques and advanced statistical tools are 
used to arrive at more accurate permutations from 
numerous droplets or particles with consideration of 
statistical errors. Polydispersity signifies the degree of 
uniformity of the droplet size in the formulation. The lower 
the value of polydispersity, then the higher the size 
uniformity of the formulation. The uniformity of size allows 
for better prediction of fate of drug based on size-dependent 
pharmacokinetics. 
(v)  Zeta potential measurement 
This is used to identify the charge of the droplets dispersed 
in an emulsion.  Most times, the charge on oil droplets in 
emulsion systems is negative due to presence of free fatty 
acids 52. 
(vi)  Viscosity and refractive index 
The viscosity of undiluted SEDDs is measured using 
viscometers or rheometers while the refractive index can be 
measured using a refractometer. The viscosity and refractive 
index are evaluated to understand the flowability and 
transparency respectively. 
Melting properties and polymorphism of lipid or drug in self 
emulsifying systems may be established by differential 
scanning calorimetry (DSC) and X-ray diffraction. 
Traditionally, preparation of SEDDS involves dissolution of 
drugs in oils and their mixing with suitable solubilizers. 
Drugs and excipients are chemical substances with 
functional groups and therefore can undergo chemical 
reactions under suitable environmental conditions. They 
also undergo physical interactions. These chemical and 
physical changes that occur in drugs and excipients can 
result in the formation of new entities with different 
chemical, physical properties and pharmacological effects. 
The drug and excipient can then be said to be unstable or 
have undergone instability or degradation. The most 
frequently encountered degradative pathways are 
hydrolysis and oxidation-reduction reaction 53. Stability 
studies can be performed on pharmaceutical products to 
assess their thermal, physical and chemical stability. 
Products can be subjected to extreme temperature or stress 
and evaluated for physical and chemical changes. For 
example crystal growth and colour changes can be 
examined. Accelerated stability testing can also be 
performed to fast-track the entire process. There is a need to 
constantly conduct stability studies on self-emulsifying drug 
delivery systems. 
Lipid formulation classification system (LFCS) 
The LFCS briefly classifies lipid based formulations into four 
types according to their composition and the possible effect 
of dilution and digestion on their ability to prevent drug 
precipitation 19. The classification is presented in Table 1.
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Table 1: Lipid formulation classification system (LFCS) showing typical compositions and properties of lipid based 
drug delivery systems 
Formulation  Composition Characteristics 
Type 1 Oils without surfactant Non-dispersing, poor solvent capacity except for highly lipophilic drugs with 
high solubility in oils, requires digestion to release drug. 
Type II Oil and water insoluble 
surfactants. 
SEDDS, turbid o/w dispersions (particle size 0.25-2 µm). Unlikely to loose 
solvent capacity to dispersion, possible loss of solvent capacity on digestion. 
Type III Oils - water soluble 
surfactants and co-solvents 
SEDDS/SMEDDS, slightly bluish to clear dispersion, may lose its solvent 
capacity upon dispersion or digestion, less easily digested 
Types IV Water-soluble surfactants 
and co-solvents (oil free) 
Forms a clear micellar solution upon dispersion, likely lose solvent capacity 
on dispersion, unlikely to be digested. 
 
Solid self-emulsifying drug delivery systems (solid 
SEDDS) 
SEDDS are usually prepared as liquid dosage forms because 
many excipients used in SEDDS are liquid at ambient 
temperature. However, due to the benefits of solid dosage 
forms, solid SEDDS (S-SEDDS) have been extensively 
investigated recently. Solid SEDDS can be presented as self-
emulsifying capsules, dry emulsions, solid dispersions, 
tablets, beads, pellets, microspheres/nanoparticles, 
suppositories, implants etc. The common methods for 
transforming liquid and semi-solid lipid formulations into 
solid particles, powder or granules are spray drying, melt 
granulation, adsorption onto solid carriers, spray cooling, 
melt extrusion, super-critical fluid based methods and other 
established techniques 54. Equipment such as rotary 
pressure, two fluid or ultrasonic atomizers is used for spray 
cooling to atomize the liquid mixture and consequently 
generate droplets 55. 
Spray drying would require the atomization of the 
solubilized liquid formulation into a spray of droplets which 
are introduced into a drying chamber. The water evaporates, 
with the formation of dry particles under controlled 
temperature and air flow conditions. Solid SMEDDS has been 
prepared like this for the delivery of nimodipine using 
dextran as a solid carrier 56. 
Free flowing powders may be obtained from liquid self-
emulsifying formulation by adsorption of the liquid onto 
solid carriers. Silica, silicates, magnesium trisilicate, talcum, 
magnesium hydroxide, crospovidone and cross-linked 
sodium carboxymethyl cellulose are typical solid carriers. 
Enough quantities of SEDDS can be adsorbed at high 
quantities (up to 70 %w/w) onto suitable   carriers 57. In 
melt granulation, powder agglomeration is obtained through 
the addition of a binder that melts or softens at relatively low 
temperatures. Extrusion is a production process which 
involves conversion of raw materials with plastic properties 
into a product of uniform shape and density, by forcing it 
through a die under controlled temperature, pressure, and 
flow 58. The conditions or variables determine the nature of 
final product obtained. 
A supercritical fluid-based method can also be employed 
either for coating of drug particles or for producing solid 
dispersions. The coating process entails dispersing the drug 
particles as powder in a supercritical fluid containing one or 
more dissolved coating materials. The supercritical fluid 
popularly used is supercritical carbon dioxide. The technique 
has been successfully applied for the enhancement of 
bioavailability of carbamazepine 59.  
New applications of SEDDS 
Enteric-coated dry emulsion formulations have been newly 
developed for potential application in the oral delivery of 
peptide and protein drugs 60. These formulations consist of a 
surfactant, a vegetable oil and a pH-sensitive polymer. Oral 
delivery of β- lactamase in a self-nanoemulsifying emulsion 
improved its bioavailability relative to the free solution 61. 
Self-emulsifying tablets of non-steroidal anti-inflammatory 
drugs can be formulated to reduce incidents of gastro 
intestinal bleeding by increasing the drugs penetration 
through the GI mucosal membrane. 
Presentation of lipid liquid formulation as a solid dosage 
form combines the advantages of lipid-based drug delivery 
systems with those of solid dosage forms. Gelled self-
emulsifying formulations (SEFs) have been developed to 
greatly decrease the quantity of solidifying excipients 
required to transform SEFs into solid dosage forms, 62. In this 
study, colloidal silicon dioxide (Aerosil® 200) was applied as 
a gelling agent for the oily preparations. Colloidal silicon 
dioxide served two functions by reducing the amount of 
solidifying materials required and decreasing rate of drug 
release, thereby achieving controlled drug delivery. 
In another research, SE powder formulation was prepared 
for the purpose of enhancing the dissolution and absorption 
of griseofulvin, a poorly water-soluble drug 63. Here, a 
significant enhancement in dissolution (without ultra-
micronisation) and bioavailability of griseofulvin was 
observed. Also a novel solid SEF of dexibuprofen was 
developed using spray drying technique 64. Aerosil® 200 was 
used as an inert solid carrier which adsorbs the liquid 
formulation. This allows the drug to be presented as self-
emulsifying solid preparation. Solid SEDDS have been used in 
the delivery of diclofenac using goat fat and Tween® 65 65. 
Good drug release profile was observed with acceptable 
tablet properties. Also, improved oral bioavailability of 
halofantrine base was observed when formulated as a lipidic 
self-emulsifying drug delivery system 66.  
A new way for oral delivery of drugs with high solubility and 
low permeability was developed using self-double 
emulsifying drug delivery system (SDEDDS) 67. SDEDDS can 
spontaneously emulsify to water-in-oil-in-water (w/o/w) 
double emulsions in gastrointestinal fluid, with drugs 
entrapped in the internal water phase of the double 
emulsions. SDEDDS was employed to improve the oral 
absorption of pidotimod, a peptide like drug with high 
solubility and low permeability (class III of 
Biopharmaceutics classification system). Self-emulsifying 
phospholipid suspensions have been used to enhance the 
bioavailability and retinal accumulation of lutein 68. Ability of 
any formulation to keep a drug in solubilized form in vivo is 
essential for bioavailability. In this case, rather than using 
excess surfactant (with its toxicity issues), high amount of 
phospholipid and relatively low amount of surfactant/ 
cosurfactant was used.  
Positively charged self-emulsifying oil formulations (SEOF) 
have shown increased charge dependent interactions with 
human intestinal epithelial cells using Caco-2 cell model 69. It 
was suggested that positively charged SEOF caused 
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increased closer adhesion of the droplets to the cell surface 
due to the electrostatic attraction. Many physiological 
studies have proved that the apical potential of absorptive 
cells and other cells in the body is negatively charged with 
respect to the mucosal solution in the lumen 70. A novel 
nanoparticle drug delivery system consisting of chitosan and 
glyceryl monooleate (GMO) was developed for the effective 
delivery of paclitaxel. These chitosan/ GMO nanoparticles, 
with bioadhesive properties increased cellular association 
and was prepared by multiple emulsion (o/w/o) solvent 
evaporation methods 71. Insulin egg yolk dispersion in self-
microemulsifying system have been shown to suppress 
insulin release in pH 7.4 phosphate buffer and protect it from 
enzymatic degradation in vitro in the presence of 
chymotrypsin 72. A self-nanoemulsifying drug delivery 
system (SNEDDS) was developed for the oral delivery of 
zedoary turmeric oil (ZTO), an essential oil extracted from 
the dry rhizome of Curcuma zedoaria 73. ZTO is a mixture of 
structurally diverse compounds which are volatile and 
unstable under ambient condition. In another study, solid SE 
sustained-release microspheres of zedoary turmeric oil (oil 
phase) was prepared using the quasi-emulsion-solvent-
diffusion method involving spherical crystallization 74. The 
plasma concentration-time profiles after oral administration 
in rabbits showed a bioavailability of 135.6% compared with 
the conventional liquid SEFs. In a study, the surfactant-co-
surfactant blend of Witepsol®H35 and Solutol® HS15 caused 
enough decrease in free energy to stabilize the system75. 
Nanosized self-emulsifying lipid vesicles have also been used 
as carriers for effective delivery of lipophilic dietary 
supplements 76. These carrier systems were proposed as 
alternatives to liposomes.  
Oral pellets are known to overcome the poor and variable 
GIT absorption of drugs and have shown the capacity to 
minimize the influence of food on bioavailability. A new 
method has been developed for preparing self-emulsifying 
pellets by wet granulation technique using binder solution 
containing mono- and diglyceride oils, polysorbate 80 and 
the anti-inflammatory drug, nimesulide as a model active 
pharmaceutical ingredient 77. In vivo studies indicated 
significantly higher bioavailability of the prepared pellets 
relative to liquid emulsion form. A comparative 
bioavailability study of progesterone from self-emulsifying 
pellet formulation, self-emulsifying solution, capsule and 
aqueous suspension was performed in dogs 78. A 100% drug 
release was observed within a very short time for the self-
emulsifying formulations. Plasma drug concentration was 
significantly higher when the drug was orally administered 
from self-emulsifying pellets and self-emulsifying solution at 
equal dose with others. A study demonstrated that 
extrusion/ spheronization technique can be used as a large-
scale production method for preparing solid pellets om the 
liquid precursors to improve oral absorption and 
bioavailability 79. SE pellets of nitrendipine, a hydrophobic 
drug, were prepared using this technique. Another study 
showed that the release of methyl hydroxybenzoate 
(methylparaben) and propyl hydroxybenzoate 
(propylparaben) from pellet formulations could be 
controlled by incorporating them into self-emulsifying 
systems containing water-soluble plasticizer and talc 80.  
An isotropic formulation of loratadine consisting of Captex® 
200, Cremophore® EL and Capmul® MCM have been 
prepared as Self-emulsifying beads 81. The SE mixture was 
loaded onto polypropylene beads (PPB) using the solvent 
evaporation method. Formulations were optimized for 
loading efficiency and in vitro drug release. 
An in vitro release study showed that a prolonged release 
self-emulsifying PLGA wafers of carmustine released 
entrapped drug for 7 days which explains the observed 
higher in vitro anti-tumor activity 82. Another research 
showed the formulation of self-emulsifying solid lipid 
microparticles as viable systems for delivery of 
glibenclamide 83. 
An interesting technique for improving the oral 
bioavailability of poorly soluble drugs is the use of the 
concept of supersaturation for design of supersaturable 
formulations. Supersaturable SEDDS formulations have been 
designed and developed to reduce the surfactant side effects 
and achieve rapid absorption of poorly soluble drugs 84. The 
supersaturable SEDDS formulations contain a lower level of 
surfactant and also contain polymeric precipitation inhibitor 
to yield and stabilize a drug in a temporarily supersaturated 
state. Hydroxypropyl methylcellulose (HPMC) and related 
cellulose polymers are known to inhibit crystallization and 
thereby create the supersaturated state 85. Supersaturation 
allows activity of drug beyond its solubility limit and 
facilitates drug passage across the biological barrier 86.  
In terms of future outlook, as scientists continue to discover 
new drug moieties with poor aqueous solubility, there would 
always be the need for an appropriate drug delivery system. 
Highly lipophilic drugs are always candidates for SEDDS. 
Furthermore, advanced research in the field of biotechnology 
has produced numerous bioactive protein and peptide 
molecules which require special formulation techniques. 
Self-emulsifying drug delivery systems are gradually 
showing some promise as a platform for effective oral 
delivery of these biological substances. SEDDS would also be 
useful in the delivery of phytopharmaceuticals. Recently 
many plant derived bioactives including volatile oils, have 
been formulated as self-emulsifying lipid formulations.  
Many pharmaceutical products based on self-emulsifying 
drug delivery systems have been marketed.  
Conclusion 
Self-emulsifying formulations (SEFs) allow oil-soluble 
bioactive entities to be effectively dispersed in a lipid and 
solubilized for improved dissolution, absorption and 
bioavailability. Upon dispersion in GIT fluid, these 
formulations self-emulsify, thereby generating fine droplets 
of disperse phase. As more chemical moieties and lead 
compounds are discovered with poor aqueous solubility, 
SEDDS or SEFs are increasingly becoming attractive as 
delivery systems. Also ethnomedicines are promising 
candidates to be presented using SEDDS. More research need 
to be performed to investigate drug targeting using these 
systems. 
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